Volume 91, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Dengue virus infection is the most widespread mosquito-borne viral infection in humans and has emerged as a serious global health challenge. In the absence of effective treatment and vaccine, host factors including nutritional status, which may alter disease progression, need investigation. The interplay between nutrition and other infections is well-established, and modulation of nutritional status often presents a simple low-cost method of interrupting transmission, reducing susceptibility, and/or ameliorating disease severity. This review examines the evidence on the role of micronutrients in dengue virus infection. We found critical issues and often inconsistent results across studies; this finding along with the lack of sufficient literature in this field have limited our ability to make any recommendations. However, vitamins D and E have shown promise in small supplementation trials. In summary, the role of micronutrients in dengue virus infection is an exciting research area and needs to be examined in well-designed studies with larger samples.


Article metrics loading...

Loading full text...

Full text loading...



  1. Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB, , 1998. Phylogeny of the genus flavivirus. J Virol 72: 7383.
  2. Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Despres P, Briant L, Yssel H, Misse D, , 2011. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol 11: 16641673.[Crossref]
  3. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AI, Ennis FA, Nisalak A, , 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2.[Crossref]
  4. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio SI, Mercado JC, Videa E, Rodriguez Y, Perez MA, Cuadra R, Solano S, Rocha J, Idiaquez W, Gonzalez A, Harris E, , 2005. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 73: 10631070.
  5. Wilder-Smith A, Chen LH, Massad E, Wilson ME, , 2009. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis 15: 811.[Crossref]
  6. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI, , 2013. The global distribution and burden of dengue. Nature 496: 504507.[Crossref]
  7. Rothman AL, , 2012. Pathogenesis of Dengue Virus Infection. Available at: http://www.uptodate.com/contents/pathogenesis-of-dengue-virus-infection. Accessed January 5, 2013.
  8. Anderson R, King AD, Innis BL, , 1992. Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol 73: 21552159.[Crossref]
  9. Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S, , 1980. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 141: 16.[Crossref]
  10. Kurane I, Ennis FA, , 1988. Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol 69: 445449.[Crossref]
  11. Keusch GT, , 2003. The history of nutrition: malnutrition, infection and immunity. J Nutr 133: 336S340S.
  12. Chandra RK, , 1997. Nutrition and the immune system: an introduction. Am J Clin Nutr 66: 460S463S.
  13. Rice AL, Sacco L, Hyder A, Black RE, , 2000. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull World Health Organ 78: 12071221.
  14. Erickson KL, Medina EA, Hubbard NE, , 2000. Micronutrients and innate immunity. J Infect Dis 182 (Suppl 1): S5S10.[Crossref]
  15. Bhaskaram P, , 2002. Micronutrient malnutrition, infection, and immunity: an overview. Nutr Rev 60: S40S45.[Crossref]
  16. Opara EC, Rockway SW, , 2006. Antioxidants and micronutrients. Dis Mon 52: 151163.[Crossref]
  17. Filteau SM, Tomkins AM, , 1994. Micronutrients and tropical infections. Trans R Soc Trop Med Hyg 88: 13, 26.[Crossref]
  18. Bendich A, , 1993. Physiological role of antioxidants in the immune system. J Dairy Sci 76: 27892794.[Crossref]
  19. Maggini S, Wintergerst ES, Beveridge S, Hornig DH, , 2007. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr 98 (Suppl 1): S29S35.
  20. Cunningham-Rundles S, Ahrn S, Abuav-Nussbaum R, Dnistrian A, , 2002. Development of immunocompetence: role of micronutrients and microorganisms. Nutr Rev 60: S68S72.[Crossref]
  21. Maron GM, Clara AW, Diddle JW, Pleites EB, Miller L, Macdonald G, Adderson EE, , 2010. Association between nutritional status and severity of dengue infection in children in El Salvador. Am J Trop Med Hyg 82: 324329.[Crossref]
  22. Grant WB, Goldstein M, Mascitelli L, , 2010. Ample evidence exists from human studies that vitamin D reduces the risk of selected bacterial and viral infections. Exp Biol Med (Maywood) 235: 13951396.[Crossref]
  23. Bikle DD, , 2007. What is new in vitamin D: 2006–2007. Curr Opin Rheumatol 19: 383388.[Crossref]
  24. Aranow C, , 2011. Vitamin D and the immune system. J Investig Med 59: 881886.[Crossref]
  25. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H, , 2010. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91: 12551260.[Crossref]
  26. Puerta-Guardo H, Medina F, De la Cruz Hernandez SI, Rosales VH, Ludert JE, del Angel RM, , 2012. The 1alpha,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes. Antiviral Res 94: 5761.[Crossref]
  27. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zugel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A, , 2006. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36: 361370.[Crossref]
  28. Ceballos-Olvera I, Chavez-Salinas S, Medina F, Ludert JE, del Angel RM, , 2010. JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol. Virology 396: 3036.[Crossref]
  29. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, , 2000. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183188.[Crossref]
  30. Alagarasu K, Bachal RV, Bhagat AB, Shah PS, Dayaraj C, , 2012. Elevated levels of vitamin D and deficiency of mannose binding lectin in dengue hemorrhagic fever. Virol J 9: 86.[Crossref]
  31. Albuquerque LM, Trugilho MRO, Chapeaurouge A, Jurgilas PB, Bozza PT, Bozza FA, Perales J, Neves-Ferreira AGC, , 2009. Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res 8: 54315441.[Crossref]
  32. Alagarasu K, Honap T, Mulay AP, Bachal RV, Shah PS, Cecilia D, , 2012. Association of vitamin D receptor gene polymorphisms with clinical outcomes of dengue virus infection. Hum Immunol 73: 11941199.[Crossref]
  33. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, Hill A, , 2002. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 67: 102106.
  34. Sánchez-Valdéz E, Delgado-Aradillas M, Torres-Martínez JA, Torres-Benítez JM, , 2009. Clinical response in patients with dengue fever to oral calcium plus vitamin D administration: study of 5 cases. Proc West Pharmacol Soc 52: 1417.
  35. Shankar AH, Prasad AS, , 1998. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68: 447S463S.
  36. Ferencik M, Ebringer L, , 2003. Modulatory effects of selenium and zinc on the immune system. Folia Microbiol (Praha) 48: 417426.[Crossref]
  37. Yakoob MY, Theodoratou E, Jabeen A, Imdad A, Eisele TP, Ferguson J, Jhass A, Rudan I, Campbell H, Black RE, Bhutta ZA, , 2011. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 11 (Suppl 3): S23.[Crossref]
  38. Roth DE, Richard SA, Black RE, , 2010. Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials. Int J Epidemiol 39: 795808.[Crossref]
  39. Shafee N, AbuBakar S, , 2002. Zinc accelerates dengue virus type 2-induced apoptosis in Vero cells. FEBS Lett 524: 2024.[Crossref]
  40. Jan JT, Chen BH, Ma SH, Liu CI, Tsai HP, Wu HC, Jiang SY, Yang KD, Shaio MF, , 2000. Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J Virol 74: 86808691.[Crossref]
  41. Yuliana N, Fadil RMR, Chairulfatah A, , 2009. Serum zinc levels and clinical severity of dengue infection in children. Paediatr Indones 49: 309.[Crossref]
  42. Widagdo, 2008. Blood zinc levels and clinical severity of dengue hemorrhagic fever in children. Southeast Asian J Trop Med Public Health 39: 610616.
  43. Thurnham DI, , 1997. Micronutrients and immune function: some recent developments. J Clin Pathol 50: 887891.[Crossref]
  44. Mehta S, Fawzi W, , 2007. Effects of vitamins, including vitamin A, on HIV/AIDS patients. Vitam Horm 75: 355383.[Crossref]
  45. Glasziou PP, Mackerras DE, , 1993. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 306: 366370.[Crossref]
  46. Villamor E, Fawzi WW, , 2005. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 18: 446464.[Crossref]
  47. Hussey GD, Klein M, , 1990. A randomized, controlled trial of vitamin a in children with severe measles. N Engl J Med 323: 160164.[Crossref]
  48. Klassen P, Biesalski HK, Mazariegos M, Solomons NW, Fürst P, , 2004. Classic dengue fever affects levels of circulating antioxidants. Nutrition 20: 542547.[Crossref]
  49. Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I, , 2005. The effect of iron deficiency anemia on the function of the immune system. Hematol J 5: 579583.[Crossref]
  50. Chaiyaratana W, Chuansumrit A, Atamasirikul K, Tangnararatchakit K, , 2008. Serum ferritin levels in children with dengue infection. Southeast Asian J Trop Med Public Health 39: 832836.
  51. Assessing the iron status of populations: including literature reviews: report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level, Geneva, Switzerland, April 6–8, 2004. 2nd ed. Pages 1011.
  52. Shrivastava R, Upreti RK, Seth PK, Chaturvedi UC, , 2002. Effects of chromium on the immune system. FEMS Immunol Med Microbiol 34: 17.[Crossref]
  53. Gavin IM, Gillis B, Arbieva Z, Prabhakar BS, , 2007. Identification of human cell responses to hexavalent chromium. Environ Mol Mutagen 48: 650657.[Crossref]
  54. Shrivastava R, Srivastava S, Upreti R, Chaturvedi U, , 2005. Effects of dengue virus infection on peripheral blood cells of mice exposed to hexavalent chromium with drinking water. Indian J Med Res 122: 111119.
  55. Shrivastava R, Upreti RK, Chaturvedi UC, , 2005. Effects of dengue virus infection on the spleen of male mice given hexavalent chromium with drinking water. Toxicol Mech Methods 15: 323329.[Crossref]
  56. Shrivastava R, Upreti RK, Chaturvedi UC, , 2003. Various cells of the immune system and intestine differ in their capacity to reduce hexavalent chromium. FEMS Immunol Med Microbiol 38: 6570.[Crossref]
  57. Glaser U, Hochrainer D, Kloppel H, Kuhnen H, , 1985. Low level chromium (VI) inhalation effects on alveolar macrophages and immune functions in Wistar rats. Arch Toxicol 57: 250256.[Crossref]
  58. Shrivastava R, Nagar R, Ravishankar G, Upreti R, Chaturvedi U, , 2007. Effect of pretreatment with chromium picolinate on haematological parameters during dengue virus infection in mice. Indian J Med Res 126: 440446.
  59. Beharka A, Redican S, Leka L, Meydani SN, , 1997. Vitamin E status and immune function. Methods Enzymol 282: 247263.[Crossref]
  60. Tanaka J, Fujiwara H, Torisu M, , 1979. Vitamin E and immune response. I. Enhancement of helper T cell activity by dietary supplementation of vitamin E in mice. Immunology 38: 727734.
  61. Meydani SN, Barklund MP, Liu S, Meydani M, Miller RA, Cannon JG, Morrow FD, Rocklin R, Blumberg JB, , 1990. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 52: 557563.
  62. Gay R, Meydani SN, , 2001. The effects of vitamin E, vitamin B6, and vitamin B12 on immune function. Nutr Clin Care 4: 188198.[Crossref]
  63. Vaish A, Verma S, Agarwal A, Gupta L, Gutch M, , 2012. Effect of vitamin E on thrombocytopenia in dengue fever. Ann Trop Med Public Health 5: 282285.[Crossref]
  64. Klassen P, Biesalski HK, Mazariegos M, Solomons NW, Fürst P, , 2004. Classic dengue fever affects levels of circulating antioxidants. Nutrition 20: 542547.[Crossref]
  65. Bockow B, Kaplan TB, , 2013. Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: two case reports. J Med Case Rep 7: 91.[Crossref]
  66. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, Dunstan SJ, Wills B, Farrar J, Van Tram T, Gan TT, Binh NT, Tri le T, Lien le B, Tuan NM, Tham NT, Lanh MN, Nguyet NM, Hieu NT, Van N, Vinh Chau N, Thuy TT, Tan DE, Sakuntabhai A, Teo YY, Hibberd ML, Simmons CP, , 2011. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet 43: 11391141.[Crossref]
  67. Branda RF, Powden C, Brooks EM, Yildirim Z, Naud SJ, McCormack JJ, , 2006. Vitamin E but not St. John's wort mitigates leukopenia caused by cancer chemotherapy in rats. Transl Res 148: 315324.[Crossref]
  68. Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, Farahani M, Li Y, van Widenfelt E, Page JB, Bussmann H, Fawzi WW, Moyo S, Makhema J, Thior I, Essex M, Marlink R, , 2013. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial. JAMA 310: 21542163.[Crossref]
  69. Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K, Meydani SN, Fawzi WW, , 2008. A trial of the effect of micronutrient supplementation on treatment outcome, t cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis 197: 14991505.[Crossref]
  70. Mehta S, Mugusi FM, Bosch RJ, Aboud S, Chatterjee A, Finkelstein JL, Fataki M, Kisenge R, Fawzi WW, , 2011. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutr J 10: 120.[Crossref]
  71. Rocco A, Compare D, Coccoli P, Esposito C, Di Spirito A, Barbato A, Strazzullo P, Nardone G, , 2013. Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus. Gut 62: 766773.[Crossref]
  72. Hemila H, , 2004. Vitamin C supplementation and respiratory infections: a systematic review. Mil Med 169: 920925.[Crossref]
  73. da Silva MT, Silva-Jardim I, Thiemann OH, , 2014. Biological implications of selenium and its role in trypanosomiasis treatment. Curr Med Chem 21: 17721780.[Crossref]

Data & Media loading...

  • Received : 09 Mar 2014
  • Accepted : 10 Jul 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error